Sanara Medtech Inc.2025财年第一财季实现净利润-3.53百万美元，同比减少100.57%

市场透视05-23

5月23日，Sanara Medtech Inc.（SMTI.US）公布财报，公告显示公司2025财年第一财季净利润为-3.53百万美元，同比减少100.57%；其中营业收入为23.43百万美元，同比增加26.38%，每股基本收益为-0.41美元。从资产负债表来看，Sanara Medtech Inc.（SMTI.US）总负债59.71百万美元，其中短期债务229710.00美元，资产负债比为...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2537923755?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-23 00:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2537923755","market":"us","top_or_hot":-1,"title":"Sanara Medtech Inc.2025财年第一财季实现净利润-3.53百万美元，同比减少100.57%","media":"市场透视","content":"<div>\n<p>5月23日，Sanara Medtech Inc.（SMTI.US）公布财报，公告显示公司2025财年第一财季净利润为-3.53百万美元，同比减少100.57%；其中营业收入为23.43百万美元，同比增加26.38%，每股基本收益为-0.41美元。从资产负债表来看，Sanara Medtech Inc.（SMTI.US）总负债59.71百万美元，其中短期债务229710.00美元，资产负债比为...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000047a488764d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanara Medtech Inc.2025财年第一财季实现净利润-3.53百万美元，同比减少100.57%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanara Medtech Inc.2025财年第一财季实现净利润-3.53百万美元，同比减少100.57%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-23 00:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000047a488764d&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>5月23日，Sanara Medtech Inc.（SMTI.US）公布财报，公告显示公司2025财年第一财季净利润为-3.53百万美元，同比减少100.57%；其中营业收入为23.43百万美元，同比增加26.38%，每股基本收益为-0.41美元。从资产负债表来看，Sanara Medtech Inc.（SMTI.US）总负债59.71百万美元，其中短期债务229710.00美元，资产负债比为...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000047a488764d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SMTI","symbol_name":"Sanara MedTech Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000047a488764d&s=b","article_id":"2537923755","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000047a488764d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2537923755","pubTimestamp":1747929622,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"5月23日，Sanara Medtech Inc.公布财报，公告显示公司2025财年第一财季净利润为-3.53百万美元，同比减少100.57%；其中营业收入为23.43百万美元，同比增加26.38%，每股基本收益为-0.41美元。从资产负债表来看，Sanara Medtech Inc.总负债59.71百万美元，其中短期债务229710.00美元，资产负债比为1.62，流动比率为2.78。机构评级：截至2025年5月23日，当前有2家机构对Sanara Medtech Inc.目标价做出预测，其中目标均价为49.00美元，其中最低目标价为45.00美元，最高目标价为53.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"SMTI":"Sanara MedTech Inc."},"translate_title":"Sanara Medtech Inc. achieved net profit of-3.53 million US dollars in the first fiscal quarter of fiscal year 2025, a year-on-year decrease of 100.57%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SMTI":0.9},"content_text":"5月23日，Sanara Medtech Inc.（SMTI.US）公布财报，公告显示公司2025财年第一财季净利润为-3.53百万美元，同比减少100.57%；其中营业收入为23.43百万美元，同比增加26.38%，每股基本收益为-0.41美元。从资产负债表来看，Sanara Medtech Inc.（SMTI.US）总负债59.71百万美元，其中短期债务229710.00美元，资产负债比为1.62，流动比率为2.78。机构评级：截至2025年5月23日，当前有2家机构对Sanara Medtech Inc.目标价做出预测，其中目标均价为49.00美元，其中最低目标价为45.00美元，最高目标价为53.00美元。公司简介：Sanara MedTech Inc 是一家医疗技术公司，专注于开发和商业化变革性技术，以改善临床结果并减少慢性和手术伤口和护肤市场的医疗保健支出。其产品和服务组合使其能够为包括急性和急性后护理在内的所有护理环境中的患者提供全面的伤口和护肤解决方案。其手术伤口护理产品是 CellerateRX手术活化胶原蛋白。其慢性伤口护理产品是BIAKOS皮肤和伤口清洁剂和BIAKOS皮肤和伤口凝胶。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2537923755","isCrawlerRequest":true}